LL-37
LL-37. The body's endogenous antimicrobial peptide, with immunomodulatory and wound-healing roles.
How it works. Disrupts bacterial membranes directly while also modulating host immune signaling, chemotaxis, and wound-healing pathways.
What the research supports. 2 graded claims. Strongest: Activity against resistant organisms in research (preclinical).
Hormonal impact. Effects on Vitamin D-dependent transcription, Inflammatory cytokines.
Side effects and interactions. 0 medication interactions listed. Serious: Pro-inflammatory if dosed inappropriately.
Stacking. Pairs well with Adequate vitamin D status. Avoid combining with Autoimmune skin disease flares.
Common forms. Available as Topical, Subcutaneous injection (research).
Community. Experiences from people who have tried LL-37. Anecdotes are not medical advice.
LL-37. The body's endogenous antimicrobial peptide, with immunomodulatory and wound-healing roles.
What it is
LL-37 is the active fragment of human cathelicidin (hCAP-18), produced by neutrophils and epithelial cells as part of innate immunity.
Also called
How it works
Disrupts bacterial membranes directly while also modulating host immune signaling, chemotaxis, and wound-healing pathways.
Pathways
- Bacterial membrane disruption
- Chemotaxis (FPR2)
- Wound-healing signaling
Effects
- ⊘Broad-spectrum bacterial activity inhibits
- +Wound re-epithelialization supports
- +Innate immune recruitment supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Hormonal impact
Side effects & interactions
Common side effects
- Local irritation at site of application
Serious
- Pro-inflammatory if dosed inappropriately
No notable medication interactions listed.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Adequate vitamin D statusVitamin D regulates endogenous expression.
Avoid combining
- Autoimmune skin disease flaresMay amplify ongoing inflammation.
Common forms
- Topical
- Subcutaneous injection (research)
Discussion
Loading discussion…